157 related articles for article (PubMed ID: 7700265)
1. A non-isotopic nested polymerase chain reaction method to quantitate minimal residual disease in patients with non-Hodgkin's lymphoma.
Hétu F; Coutlée F; Roy DC
Mol Cell Probes; 1994 Dec; 8(6):449-57. PubMed ID: 7700265
[TBL] [Abstract][Full Text] [Related]
2. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
3. Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach.
Deggerdal AH; Pettersen F; Kvalheim G; Hornes E; Smeland E; Fodstad O; Hovig E
Lab Invest; 1995 Apr; 72(4):411-8. PubMed ID: 7723279
[TBL] [Abstract][Full Text] [Related]
4. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
Chan DW; Liang R; Kwong YL; Chan V
Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
[TBL] [Abstract][Full Text] [Related]
5. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
[TBL] [Abstract][Full Text] [Related]
6. Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing.
Kneba M; Eick S; Herbst H; Willigeroth S; Pott C; Bolz I; Bergholz M; Neumann C; Stein H; Krieger G
Cancer Res; 1991 Jun; 51(12):3243-50. PubMed ID: 2039999
[TBL] [Abstract][Full Text] [Related]
7. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E
Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
[TBL] [Abstract][Full Text] [Related]
8. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
9. Large variation in t(11;14)(q13;q32) and t(14;18)(q32;q21) translocation product size is confirmed by sequence analysis of PCR products.
Wickham CL; Harries LW; Sarsfield P; Joyner MV; Ellard S
Clin Lab Haematol; 2006 Aug; 28(4):248-53. PubMed ID: 16898964
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of residual disease in non-Hodgkin's lymphomas by quantitative PCR (preliminary report).
Slavícková A; Ullmannová V; Benesová E; Klener P
Folia Biol (Praha); 1999; 45(5):179-83. PubMed ID: 10730886
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources.
Léonard BM; Hétu F; Busque L; Gyger M; Bélanger R; Perreault C; Roy DC
Blood; 1998 Jan; 91(1):331-9. PubMed ID: 9414302
[TBL] [Abstract][Full Text] [Related]
12. Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD).
Olsson K; Gerard CJ; Zehnder J; Jones C; Ramanathan R; Reading C; Hanania EG
Leukemia; 1999 Nov; 13(11):1833-42. PubMed ID: 10557059
[TBL] [Abstract][Full Text] [Related]
13. Detection of residual disease in translocation (14;18) positive non-Hodgkin's lymphoma, using the polymerase chain reaction: a comparison with conventional staging methods.
Lambrechts AC; de Ruiter PE; Dorssers LC; van 't Veer MB
Leukemia; 1992 Jan; 6(1):29-34. PubMed ID: 1736011
[TBL] [Abstract][Full Text] [Related]
14. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
[TBL] [Abstract][Full Text] [Related]
15. 5'-->3' exonuclease-based real-time PCR assays for detecting the t(14;18)(q32;21): a survey of 162 malignant lymphomas and reactive specimens.
Estalilla OC; Medeiros LJ; Manning JT; Luthra R
Mod Pathol; 2000 Jun; 13(6):661-6. PubMed ID: 10874671
[TBL] [Abstract][Full Text] [Related]
16. [Detection and diagnostic value of t(14;18) translocation in minimal residual disease of follicular lymphoma].
Bessenyei B; Urbán L; Takács I; Zeher M; Szegedi G; Semsei I
Orv Hetil; 2000 Jul; 141(31):1715-9. PubMed ID: 10976195
[TBL] [Abstract][Full Text] [Related]
17. Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.
Moos M; Schulz R; Cremer F; Sucker C; Schmohl D; Döhner H; Goldschmidt H; Haas R; Hunstein W
Stem Cells; 1995 Dec; 13 Suppl 3():42-51. PubMed ID: 8747988
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnosis in hematopoietic malignancy].
Hoshino A; Funato T; Sasaki T
Rinsho Byori; 1996 Feb; 44(2):120-5. PubMed ID: 8851193
[TBL] [Abstract][Full Text] [Related]
19. Detection and quantitation of low numbers of chromosomes containing bcl-2 oncogene translocations using semi-nested PCR.
Zhang XY; Ehrlich M
Biotechniques; 1994 Mar; 16(3):502-7. PubMed ID: 8185925
[TBL] [Abstract][Full Text] [Related]
20. [Detection of residual disease in follicular lymphomas using the PCR technique: importance of clono-specific probes].
al Saati T; Galoin S; Roda D; Huynh A; Attal M; Delsol G
Bull Cancer; 1998 Oct; 85(10):847-54. PubMed ID: 9835862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
